Американское общество гирудотерапии

Asymptomatic Mild-to-Moderate Carotid Stenosis (Investigational Adjunct)

Investigational adjunct for asymptomatic mild-to-moderate carotid stenosis; risk-factor management (statin, antiplatelet, blood pressure, smoking cessation, glycemic control) remains evidence-based; symptomatic or high-grade disease requires vascular surgery referral.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for carotid stenosis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational, with no efficacy or safety data in this population, and direct cervical placement is contraindicated.
Какие доказательства существуют?
Tier C (investigational). There are no published controlled trials and only mention-level anecdotal references. Evidence-based management of asymptomatic 50 to 69 percent carotid stenosis is aggressive risk-factor optimization: high-intensity statin, antiplatelet therapy, blood pressure under 140/90, smoking cessation, glycemic control if diabetic, and lifestyle modification. Carotid endarterectomy or stenting is reserved for symptomatic disease or asymptomatic stenosis over 80 percent in selected low-perioperative-risk patients. Duplex ultrasound surveillance is standard.
Основные риски
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Local bruising and tenderness for 5 to 10 days
  • Aeromonas hydrophila infection (rare)
  • Allergic reaction to leech saliva (uncommon)
  • Failure to address the disease itself — no stroke risk reduction is expected from this therapy
  • Delay of evidence-based risk-factor management (statin, antiplatelet, blood pressure, smoking cessation, glycemic control)
  • Bleeding risk if concurrent antiplatelet therapy is active
  • Hypothetical but real risk if a practitioner places a leech in the anterior cervical triangle near the carotid artery (this is absolutely contraindicated)
Кому не следует это рассматривать
  • Anyone with symptoms of TIA or stroke (urgent vascular evaluation)
  • Patients with high-grade stenosis over 80 percent (vascular surgery referral)
  • Patients on dual antiplatelet therapy or anticoagulants
  • Patients who have had carotid endarterectomy or stenting
  • Patients with bleeding disorders or severe anemia
  • Anyone offered direct cervical placement (this is absolutely contraindicated; only trapezius or upper shoulder is acceptable)
О чём спросить врача
  • What is the current stenosis percentage on duplex ultrasound, and is it mild, moderate, or severe?
  • Am I on a high-intensity statin, antiplatelet therapy, and have I optimized blood pressure, glycemic control, and tobacco use?
  • Do I need vascular surgery referral now or surveillance only?
  • Where exactly will the leech be placed — confirm it is NOT in the anterior neck near the carotid?
  • What is the practitioner's experience with this indication?
  • Is there any plausible mechanism that would benefit my stenosis itself?
Когда срочно обратиться за медицинской помощью
  • Sudden weakness or numbness of face, arm, or leg, especially on one side
  • Sudden trouble speaking, understanding speech, or vision loss
  • Sudden severe headache, dizziness, or loss of balance
  • Brief or transient version of any of the above (possible TIA)
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, warmth, or pus around any bite site, or fever above 38.0 C / 100.4 F

Что это НЕ означает

  • Leeches are never placed near the carotid arteries themselves — the only acceptable site is trapezius or upper shoulder skin, far from the cervical vessels.
  • It does not reduce stroke risk and does not substitute for statin, antiplatelet, blood-pressure, glycemic, or smoking-cessation therapy.
  • Symptomatic disease (TIA, stroke) or high-grade stenosis requires immediate vascular surgery referral, not investigational adjuncts.
  • Only anecdotal mention exists; no efficacy or safety data in this population.

Clinical Profile

Category
vascular
ICD-10
I65.21, I65.22, I65.23, I65.29
Safety tier
high

Evidence Summary

Asymptomatic carotid stenosis of 50-69 percent is managed by aggressive risk-factor optimization (high-intensity statin, antiplatelet therapy, blood pressure control under 140/90, smoking cessation, glycemic control in diabetes, lifestyle modification). Carotid endarterectomy or stenting is reserved for symptomatic disease or asymptomatic stenosis >80 percent in selected low-perioperative-risk patients. Duplex ultrasound surveillance is standard. No published controlled trials of hirudotherapy exist for carotid atherosclerosis. Mechanistic rationale would invoke anticoagulant and anti-inflammatory effects of leech saliva, but no human evidence supports plaque stabilization or stroke risk reduction, and direct cervical placement is high-risk for arterial proximity, vagal effects, and inadvertent injury to the carotid bulb.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Active deep vein thrombosis (acute phase <2 weeks)
  • Critical limb ischemia (ABI <0.4)
  • Symptomatic carotid disease (TIA, stroke) — refer vascular surgery
  • High-grade stenosis (>80 percent) — refer vascular surgery
  • Direct cervical or carotid-region placement (absolute)
  • Concurrent antiplatelet therapy with bleeding risk
  • Prior carotid endarterectomy or stenting

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Asymptomatic Mild-to-Moderate Carotid Stenosis (Investigational Adjunct) — Hirudotherapy Evidence | ASH